Navigation Links
Will Rogers Institute to Honor World's Leading Geneticist and Recent Medal of Freedom Recipient, Dr. Francis S. Collins For His Outstanding Contribution to Lung Research.
Date:11/27/2007

Resulting in the advancement of treatment Of Cystic Fibrosis

LOS ANGELES, Nov. 27 /PRNewswire/ -- It is impossible to over estimate the effect Dr. Francis S. Collins' work has had on public health. Fifty years ago, children living with cystic fibrosis (CF) would not have been expected to live past their early teens. Thanks to the research work of Dr. Collins, and the subsequent advancement in treatment, people can now expect to live into their thirties, forties and beyond.

It is in recognition of his extraordinary work on the CF gene and identification of the human genome, that the Will Rogers Institute (WRI) will honor Dr. Collins with the inaugural "Annual Prize for Outstanding Contributions to Lung Research." The award will be presented on Thursday, December 6, 2007 at the WRI Board of Directors Meeting at the Beverly Hills Hotel.

Dr. Collins' seminal research led to the identification of the CF gene and its protein product, CFTR. Mutation of the gene results in CF, a chronic disease which attacks the lungs and other organs. It is estimated that 30,000 children and adults in the United States struggle with cystic fibrosis. More than 10 million Americans are unknowing, symptom-free carriers of the disease, which can only be identified by genetic testing.

His work has proved to be a motivator for advancements in many other genetic investigations including type 2 diabetes, neurofibromatosis and Huntington's disease.

Dr. Edward Crandall, PhD, MD, medical advisor to the Will Rogers Institute and Hastings Professor and Norris Chair of Medicine at the University of Southern California (USC), stated, "Dr. Collins was chosen by the WRI as the first recipient of the prize because his work has consistently produced outstanding and influential research that has been published in the foremost peer-review journals. He maintains a very important leadership role in his field, and is held in the highest esteem by scientists and clinicians throughout the world."

As further testament to the importance of his work, on November 5, 2007 President George W. Bush presented Dr. Collins with the Medal of Freedom, one of the nation's highest civilian honors, for his contribution to genetic research. The Human Genome Project identified the genes in human DNA, stored the data and made it available for research. This project alone has revolutionized genetic research.

A native of the east coast, Dr. Collins studied chemistry at the University of Virginia (BS) and Yale University (PhD) and received his MD from the University of North Carolina. He undertook residency training in medicine at North Carolina before returning to Yale as a Fellow in Human Genetics from 1981 to 1984. Dr. Collins was appointed Director of the National Genome Research Institute of the National Institutes of Health in 1993.

Press Contact: Jane LaBonte (310) 801-3902


'/>"/>
SOURCE Will Rogers Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Award-winning QUITPLAN(R) Services Billboard Debuts in Rogers
2. RediClinic Adds Arkansas Blue Cross and Blue Shield Coverage in Fayetteville and Rogers
3. Health IT Now! Coalition Applauds Representatives Eshoo and Rogers for Introducing Health IT Legislation
4. Bryan R. Rogers Appointed President of Far West Division
5. National physician organization supports Capps-Rogers Bill at todays congressional briefing
6. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
7. The Risk Management and Patient Safety Institute Announces Annual Health Care Risk Conference Dates
8. LifeNet Health Establishes The Skin & Wound Allograft Institute
9. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
10. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
11. Portico Systems to Share Provider Network Management Best Practices at Institute for International Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... process has been in place since the RBMA was founded in 1968 with all ... Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... and College of Urgent Care Medicine will host industry leaders for the annual ... will help those in the industry adapt to the issues currently affecting urgent ...
(Date:4/28/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... which He does not. Yisrayl says with so many titles and names for the ... he says with a little Scripture, backed with a lot of research, the truth is ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-na├»ve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology: